Idenix Pharmaceuticals News (NASDAQ:IDIX)

Latest Idenix Pharmaceuticals News Headlines
DateTimeSource
Headline
07/17/20084:30PMPRNUSIdenix to Host Conference Call Discussing Second Quarter 2008 Financial Results
CAMBRIDGE, Mass., July 17 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc., (NASDAQ:IDIX) announced today that it will report its financial results for the second quarter of 2008 on Tuesday, July 29, 2008 before the U.S. financial markets open. In conjunction with the issuance of the press release, Idenix management... More...>>
06/12/20088:00AMPRNUSPositive Phase I/II Data of IDX899 Confirm Potent Antiviral Activity and Favorable Safety Profile in Treatment-Naive HIV-Infecte
CAMBRIDGE, Mass., June 12 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases, today reported phase I/II data for IDX899, a non-nucleoside reverse transcriptase... More...>>
06/04/20089:00AMPRNUSIdenix Pharmaceuticals to Present at the Seventh Annual Needham and Company, LLC Biotechnology and Medical Technology Conference
CAMBRIDGE, Mass, June 4 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX) announced today that Idenix management will present a corporate overview at the Seventh Annual Needham and Company, LLC Biotechnology and Medical Technology Conference on Thursday, June 12, 2008 at 3:30 pm. ET at The New York... More...>>
05/12/20084:00PMPRNUSIdenix Pharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
CAMBRIDGE, Mass., May 12 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX) announced today that Idenix management will present a corporate overview at the Rodman & Renshaw 5th Annual Global Healthcare Conference on Tuesday, May 20, 2008 at 12:00 p.m. CEST at Le Meridien Beach Plaza Hotel in Monte... More...>>
04/29/20088:00AMPRNUSIdenix Pharmaceuticals Reports First Quarter 2008 Financial Results
CAMBRIDGE, Mass., April 29 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases, today reported unaudited financial results for the first quarter ended March 31... More...>>
04/24/20084:00PMPRNUSIdenix Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
CAMBRIDGE, Mass., April 24 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX) announced today that Idenix management will present a corporate overview at the upcoming Morgan Stanley Global Healthcare Unplugged Conference on Wednesday, April 30, 2008 at 3:00 p.m. ET at The Ritz Carlton in Key Biscayne... More...>>
04/23/20088:00AMPRNUSIdenix Pharmaceuticals Presents Positive Preclinical Data on HCV Programs at The Annual Meeting of The European Association for
CAMBRIDGE, Mass., and MILAN, Italy, April 23 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases, today announced preclinical data from the company's polymerase... More...>>
04/17/20084:00PMPRNUSIdenix to Host Conference Call Discussing First Quarter 2008 Financial Results
CAMBRIDGE, Mass., April 17 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc., (NASDAQ:IDIX) announced today that it will report its financial results for the first quarter of 2008 on Tuesday, April 29, 2008 before the U.S. financial markets open. In conjunction with the issuance of the press release, Idenix management... More...>>
04/04/20089:00AMPRNUSIdenix Pharmaceuticals to Present at the Canaccord Adams Hepatitis C Conference
CAMBRIDGE, Mass., April 4, 2008 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX) announced today that Idenix management will present an overview of its Hepatitis C program at the upcoming Canaccord Adams Hepatitis C Conference on Wednesday, April 9, 2008 at 1:30 p.m. ET at the St. Regis Hotel in... More...>>
03/11/20084:21PMPRNUSIdenix Pharmaceuticals to Present at the Eleventh Annual Lehman Brothers Global Healthcare Conference
CAMBRIDGE, Mass., March 11 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX) announced today that Idenix management will present a corporate overview at the upcoming Eleventh Annual Lehman Brothers Global Healthcare Conference on Tuesday, March 18, 2008 at 4:15 p.m. ET at the Loews Miami Beach Hotel... More...>>
03/06/20084:05PMPRNUSIdenix Pharmaceuticals Reports Fourth Quarter and Year-End 2007 Financial Results
CAMBRIDGE, Mass., March 6 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases, today reported unaudited financial results for the fourth quarter and year ended... More...>>
03/03/20084:05PMPRNUSIdenix Pharmaceuticals To Present at the SIGnificant Investment Options in Healthcare Conference
CAMBRIDGE, Mass., March 3 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX) announced today that Idenix management will present a corporate overview at the upcoming SIGnificant Investment Options in Healthcare Conference hosted by Susquehanna Financial Group on Tuesday, March 4 at 4:30 p.m. ET at... More...>>
02/26/20084:30PMPRNUSIdenix Pharmaceuticals to Present at the SIGnificant Investment Options in Healthcare Conference
CAMBRIDGE, Mass., Feb. 26 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX) announced today that Idenix management will present a corporate overview at the upcoming SIGnificant Investment Options in Healthcare Conference hosted by Susquehanna Financial Group on Wednesday, March 5, 2008 at 4:00 p.m... More...>>
02/25/20082:23PMPRNUSIdenix Announces Data Presentations at the 43rd Annual Meeting of the European Association for the Study of the Liver (EASL)
CAMBRIDGE, Mass., Feb. 25 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases, announced today that three abstracts have been accepted for presentation at the... More...>>
02/25/20088:30AMPRNUSIdenix to Host Conference Call Discussing Fourth Quarter 2007 Financial Results
CAMBRIDGE, Mass., Feb. 25 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc., (NASDAQ:IDIX) announced today that it will report its financial results for the fourth quarter of 2007 on Thursday, March 6, 2008 after the U.S. financial markets close. In conjunction with the issuance of the press release, Idenix management... More...>>
02/06/20085:30PMPRNUSIDX899 Demonstrates Rapid and Profound Inhibition of HIV Replication in a Phase I/II Clinical Trial in Treatment-Naive HIV-Infec
CAMBRIDGE, Mass., Feb. 6 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases, today reported data for IDX899, a non-nucleoside reverse transcriptase inhibitor... More...>>
02/06/20082:18PMPRNUSIdenix Pharmaceuticals to Present at BIO CEO & Investor Conference
CAMBRIDGE, Mass., Feb. 6 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX) announced today that Idenix management will present a corporate overview at the upcoming BIO CEO & Investor Conference on Tuesday, February 12, 2008 at 9:30 a.m. ET in the Park Avenue Suite Center/North Room at the Waldorf-Astoria... More...>>
01/07/20089:07AMPRNUSIdenix Pharmaceuticals Provides Update on Hepatitis C Pipeline at JP Morgan Healthcare Conference
More...>>
01/02/20084:34PMPRNUSIdenix Pharmaceuticals To Present at the JP Morgan 26th Annual Healthcare Conference
CAMBRIDGE, Mass., Jan. 2 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX) announced today that Idenix management will present a corporate overview, including an update of the company's HCV and HIV discovery and development programs, at the upcoming JP Morgan 26th Annual Healthcare Conference on Tuesday... More...>>
01/02/20084:30PMPRNUSIdenix Pharmaceuticals To Present at the JP Morgan 26th Annual Healthcare Conference
CAMBRIDGE, Mass., Jan. 2 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX) announced today that Idenix management will present a corporate overview, including an update of the company's HCV and HIV discovery and development programs, at the upcoming JP Morgan 26th Annual Healthcare Conference on Tuesday... More...>>


LSE and PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright1999-2008 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
ADDITIONAL SERVICES AVAILABLE FROM ADVFN
Upgrade - Click here for more information on ADVFN premium services Money Words - ADVFN Financial Glossary Investor Training ADVFN Financial Bookshop Online Training Academy
34 site:2us nasdaq idix080720 06:57 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2005 | 2007 )